| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8712922 | Journal of Allergy and Clinical Immunology | 2018 | 22 Pages |
Abstract
Injections of BM32 induced allergen-specific IgG, improved clinical symptoms of seasonal grass pollen allergy, and were well tolerated.
Keywords
VASIDMCAITSPTEAACIRQLQhypoallergenicFASMedication scoreAPIAllergic rhinoconjunctivitisAllergenrecombinant allergenGrass pollen allergyAllergyEuropean Academy of Allergy and Clinical ImmunologyEfficacyAllergen immunotherapySafetySafety analysisfull analysis setSkin prick testGPSadverse eventvisual analog scaleActive Pharmaceutical Ingredientsymptom scoreHBVhepatitis B virusRhinoconjunctivitis Quality of Life QuestionnaireSMSClinical trialLeast-squaresIndependent Data Monitoring Committee
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Verena MD, Angela PhD, Philippe MD, Mihaela MD, Margitta MD, Werner MD, Hans Jørgen MD, Oliver MD, Ludger MD, Wolfgang MD, Johannes MD, Ulf MD, Natalija MD, Roy MD, Julia MD, PhD, Margarete PhD, Milena MSc, Hans-Helge PhD, Rudolf MD,